67457-211 : Fomepizole 1 g/ml Intravenous Injection, Solution
NDC: | 67457-211 |
Labeler: | Mylan Institutional LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Fomepizole |
Dosage Form: | Intravenous Injection, Solution |
Application #: | ANDA078639 |
Rev. Date: | |
CSA Schedule: | CIII (US) [1] |
[1] Schedule III / IIIN Controlled Substance: Has a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. (i.e. Products containing not more than 90 milligrams of Codeine per dosage unit [such as Tylenol with Codeine], other narcotics such as Buprenorphine (Suboxone), and Schedule IIIN non-narcotics such as Didrex, Ketamine, Phendimetrazine, and Anabolic Steroids). More Details: US Dept of Justice Controlled Substance Schedules.
NDC Package Codes:
- 67457-211-02: 1 VIAL, GLASS IN 1 CARTON (67457‑211‑02) > 1.5 ML IN 1 VIAL, GLASS
Active Ingredients:
- Fomepizole
Dosage Strength:
- 1 g/mL
Pharmaceutical Classes:
- Antidote [EPC]
Related Products:
Based on records with the same trade name.- 0517-0710 Fomepizole 1 g/ml Intravenous Injection, Solution by American Regent, Inc.
- 0781-3182 Fomepizole 1 g/ml Intravenous Injection, Solution by Sandoz Inc.
- 25021-829 Fomepizole 1 g/1.5ml Intravenous Injection by Sagent Pharmaceuticals
- 39822-0710 Fomepizole 1 g/ml Intravenous Injection, Solution by X-gen Pharmaceuticals, Inc.
- 68083-510 Fomepizole 1 g/ml Intravenous Injection by Gland Pharma Limited
- 68475-510 Fomepizole 1 g/ml Intravenous Injection, Solution by Navinta LLC
- 70710-1478 Fomepizole 1 g/ml Intravenous Injection, Solution by Zydus Pharmaceuticals USA Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 67457-210Next: 67457-212 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.